Manitou Investment Management Ltd. Has $33.28 Million Position in DENTSPLY SIRONA Inc (NASDAQ:XRAY)

Manitou Investment Management Ltd. grew its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 624,172 shares of the medical instruments supplier’s stock after purchasing an additional 4,388 shares during the quarter. DENTSPLY SIRONA comprises approximately 8.0% of Manitou Investment Management Ltd.’s investment portfolio, making the stock its 3rd largest position. Manitou Investment Management Ltd. owned approximately 0.28% of DENTSPLY SIRONA worth $33,275,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in XRAY. Altshuler Shaham Ltd grew its position in shares of DENTSPLY SIRONA by 209.8% during the 2nd quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock worth $30,000 after buying an additional 342 shares during the period. Quest Capital Management Inc. ADV acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $30,000. Cornerstone Advisors Inc. grew its position in shares of DENTSPLY SIRONA by 62.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 346 shares during the period. Van ECK Associates Corp acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $54,000. Finally, Arcadia Investment Management Corp MI acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $58,000. Hedge funds and other institutional investors own 93.46% of the company’s stock.

XRAY has been the subject of several research reports. Barclays lifted their price target on shares of DENTSPLY SIRONA from $55.00 to $58.00 and gave the company an “equal weight” rating in a research report on Friday. Stifel Nicolaus lifted their price target on shares of DENTSPLY SIRONA from $61.00 to $63.00 and gave the company a “buy” rating in a research report on Friday. Evercore ISI initiated coverage on shares of DENTSPLY SIRONA in a research report on Friday, July 26th. They issued an “in-line” rating for the company. Barrington Research reissued a “buy” rating and issued a $63.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, August 5th. Finally, Wellington Shields raised shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company’s stock. DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $57.37.

NASDAQ XRAY traded up $0.34 during mid-day trading on Friday, hitting $57.42. The company’s stock had a trading volume of 2,699,300 shares, compared to its average volume of 1,735,074. The company’s 50 day simple moving average is $53.88 and its 200 day simple moving average is $54.19. The company has a current ratio of 2.08, a quick ratio of 1.39 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $12.31 billion, a price-to-earnings ratio of 28.57, a PEG ratio of 1.97 and a beta of 0.96. DENTSPLY SIRONA Inc has a twelve month low of $34.93 and a twelve month high of $60.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.07. The business had revenue of $962.10 million during the quarter, compared to the consensus estimate of $940.38 million. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.38 earnings per share. As a group, research analysts forecast that DENTSPLY SIRONA Inc will post 2.39 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: What are the benefits of momentum investing?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit